跳至主要内容
临床试验/NCT04841330
NCT04841330已完成不适用

Prospective Healthy Volunteer Study of the Securis™ Stabilization Device

Becton, Dickinson and Company1 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2021年6月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
104
试验地点
1
主要终点
Percentage of Participants with Select Skin Conditions Observed During Securis™ Stabilization Device Use

研究概览

简要总结

This study is being conducted to assess the performance of the Securis™ Stabilization Device in simulated clinical use.

详细描述

This study is designed to collect prospective observational data related to the safety and performance of the Securis™ Stabilization Device in healthy volunteers utilizing a simulated use method. Participants will have an intravenous catheter applied (not inserted) onto their forearm with a Securis™ Stabilization Device applied over it. The site/device will be assessed over a period of 9 days (ideally Days 0-7 in-clinic and Day 8 virtually). The assessments will include the appearance of the site, the appearance of the dressing, and the movement of the catheter tip under the dressing.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥14 years of age, regardless of gender, at the time of informed consent
  • Is expected to be available through Day 8 of the study
  • Is expected to understand and follow the study procedures including applicable restrictions in activities (e.g., limited physical exercise, no swimming, no use of lotions/moisturizers, etc.)
  • Provision of signed and dated informed consent form. Note: Consent of a parent of legal guardian will be require for participants <18 years of age; assent will also be required for these participants

排除标准

  • Significant scarring at the device application site
  • Has any skin condition that might affect device adherence or the ability of study staff to perform skin assessments
  • Has any condition or is taking any medication that might cause excessive bruising, bleeding, or skin tearing (e.g., anti-coagulant therapy)
  • Known allergy to study device/components or ancillary devices
  • Will be unable to complete a remote visit via video chat, if required
  • Has any condition which, in the opinion of the Investigator, precludes them from participation in this study.

结局指标

主要结局

Percentage of Participants with Select Skin Conditions Observed During Securis™ Stabilization Device Use

时间窗: From placement and up tp to 24 hours after device removal

Select skin conditions include any of the following: * Blister * Rash * Skin tear * Bruising * Exudate

Rate of Securis™ Stabilization Device Securement Failure During Simulated Use

时间窗: From time of placement and up to 8 days after removal

Device securement failure is defined as any of the following: * Loose dressing * Soiled under dressing * Complete failure (complete removal) * Dislodgement of device or catheter

次要结局

  • Rate of Securis™ Stabilization Device-related Adverse Events(From placement and up to 24 hours after device removal)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验